Re‐evaluation of serum alanine aminotransferase upper normal limit and its modulating factors in a large‐scale population study
- 10 April 2006
- journal article
- research article
- Published by Wiley in Liver International
- Vol. 26 (4), 445-450
- https://doi.org/10.1111/j.1478-3231.2006.01197.x
Abstract
Background: The upper normal limit (ULN) of serum alanine‐aminotrasferase (ALT) normal range was recently challenged, because patients diagnosed with liver diseases may have ‘normal’ or near‐‘normal’ ALT levels, and because possible modulators are often ignored in determining normal range. Aim: To estimate the ULN for serum ALT and to identify factors modulating it. Subjects and methods: We reviewed medical records of subjects aged 15–90, who underwent standard panels of laboratory tests, including serum ALT, over 6 months at a central laboratory. Three groups were defined: Group 1, comprised total study population (N=272 273). Group 2 (N=87 020) comprised total study population, excluding those receiving potentially hepatotoxic drugs, or diagnosed with liver disease, or had any abnormal laboratory test results other than for triglycerides, cholesterol, glucose, or HbA1c. Group 3 (N=17 496) the ‘healthy’ population, from whose ALT values we established the new ULN, comprised Group 2 subjects with normal triglycerides, cholesterol, glucose, and HbA1c levels. Results: The 95th percentile ALT values, corresponding to the ULN, in groups 1, 2, and 3 were 50.1, 40, and 37.5 U/l, respectively. 6.2% (16 943/273 273) of subjects whose ALT was below ULN listed by the test manufacturer (52 U/l), had ALT level above our new ULN. Linear and logistic‐regression analyses showed that ALT levels were significantly modified by gender, age, glucose, cholesterol, triglycerides, and overweight/obesity diagnosis. Significant interaction was found between gender, glucose and cholesterol levels. Conclusions: In this first large‐scale study of ‘healthy’ population, serum ALT ULN was far lower than currently accepted value. Age and gender may be considered when determining the ULN for ALT.Keywords
This publication has 14 references indexed in Scilit:
- Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort studyBMJ, 2004
- Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT valuesHepatology, 2003
- HCV carriers with persistently normal aminotransferase levels: normal does not always mean healthyJournal of Hepatology, 2003
- Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndromeHepatology, 2003
- Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United StatesGastroenterology, 2003
- Factors associated with serum alanine transaminase activity in healthy subjects: Consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis CHepatology, 1998
- Feed-forward Neural NetworksPublished by Cambridge University Press (CUP) ,1996
- Alanine Aminotransferase in Clinical PracticeArchives of Internal Medicine, 1991
- The nature of unexplained chronic aminotransferase elevations of a mild to moderate degree in asymptomatic patientsHepatology, 1989